2024

1. Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice

   Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615

2. Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease

   Journal of Hepatology